{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:57:10Z","timestamp":1785862630085,"version":"3.56.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1124\/jpet.105.099705","type":"journal-article","created":{"date-parts":[[2006,1,26]],"date-time":"2006-01-26T01:48:47Z","timestamp":1138240127000},"page":"562-570","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Pharmacological Characterization and Feeding-Suppressive Property of FMS586 [3-(5,6,7,8-Tetrahydro-9-isopropyl-carbazol-3-yl)-1-methyl-1-(2-pyridin-4-yl-ethyl)-urea Hydrochloride], a Novel, Selective, and Orally Active Antagonist for Neuropeptide Y Y5 Receptor"],"prefix":"10.1016","volume":"317","author":[{"given":"Nobukazu","family":"Kakui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Tabata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Asai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takako","family":"Miyara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Nakatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fukuichi","family":"Ohsawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaharu","family":"Sugai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kozo","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kitaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.105.099705_bib1","doi-asserted-by":"crossref","unstructured":"Bai FL, Yamano M, Shiotani Y, Emson PC, Smith AD, Powell JF, and Tohyama M (1985) An arcuato-paraventricular and -dorsomedial hypothalamic neuropeptide Y-containing system, which lacks noradrenaline in the rat. Brain Res 331: 172\u2013175.","DOI":"10.1016\/0006-8993(85)90730-9"},{"key":"10.1124\/jpet.105.099705_bib2","doi-asserted-by":"crossref","unstructured":"Bannon AW, Seda J, Carmouche M, Francis JM, Norman MH, Karbon B, and McCaleb ML (2000) Behavioral characterization of neuropeptide Y knockout mice. Brain Res 868: 79\u201387.","DOI":"10.1016\/S0006-8993(00)02285-X"},{"key":"10.1124\/jpet.105.099705_bib3","doi-asserted-by":"crossref","unstructured":"Beck B (2001) KOs and organisation of peptidergic feeding behavior mechanisms. Neurosci Biobehav Rev 25: 143\u2013158.","DOI":"10.1016\/S0149-7634(01)00003-3"},{"key":"10.1124\/jpet.105.099705_bib4","unstructured":"Beck B, Stricker-Krongrad A, Nicolas JP, and Burlet C (1992) Chronic and continuous intracerebroventricular infusion of neuropeptide Y in Long-Evans rats mimics the feeding behaviour of obese Zucker rats. Int J Obes Relat Metab Disord 16: 295\u2013302."},{"key":"10.1124\/jpet.105.099705_bib5","doi-asserted-by":"crossref","unstructured":"Bergonzelli GE, Pralong FP, Glauser M, Cavadas C, Grouzmann E, and Gaillard RC (2001) Interplay between galanin and leptin in the hypothalamic control of feeding via corticotropin-releasing hormone and neuropeptide Y. Diabetes 50: 2666\u20132672.","DOI":"10.2337\/diabetes.50.12.2666"},{"key":"10.1124\/jpet.105.099705_bib6","doi-asserted-by":"crossref","unstructured":"Blomqvist AG and Herzog H (1997) Y-receptor subtypes\u2013how many more? Trends Neurosci 20: 294\u2013298.","DOI":"10.1016\/S0166-2236(96)01057-0"},{"key":"10.1124\/jpet.105.099705_bib7","doi-asserted-by":"crossref","unstructured":"Cabrele C, Langer M, Bader R, Wieland HA, Doods HN, Zerbe O, and Beck-Sickinger AG (2000) The first selective agonist for the neuropeptide YY5 receptor increases food intake in rats. J Biol Chem 275: 36043\u201336048.","DOI":"10.1074\/jbc.M000626200"},{"key":"10.1124\/jpet.105.099705_bib8","doi-asserted-by":"crossref","unstructured":"Campbell RE, French-Mullen JM, Cowley MA, Smith MS, and Grove KL (2001) Hypothalamic circuitry of neuropeptide Y regulation of neuroendocrine function and food intake via the Y5 receptor subtype. Neuroendocrinology 74: 106\u2013119.","DOI":"10.1159\/000054676"},{"key":"10.1124\/jpet.105.099705_bib9","doi-asserted-by":"crossref","unstructured":"Clark JT, Kalra PS, Crowley WR, and Kalra SP (1984) Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology 115: 427\u2013429.","DOI":"10.1210\/endo-115-1-427"},{"key":"10.1124\/jpet.105.099705_bib10","doi-asserted-by":"crossref","unstructured":"Criscione L, Rigollier P, Batzl-Hartmann C, Rueger H, Stricker-Krongrad A, Wyss P, Brunner L, Whitebread S, Yamaguchi Y, Gerald C, et al. (1998) Food intake in free-feeding and energy-deprived lean rats is mediated by the neuropeptide Y5 receptor. J Clin Investig 102: 2136\u20132145.","DOI":"10.1172\/JCI4188"},{"key":"10.1124\/jpet.105.099705_bib11","doi-asserted-by":"crossref","unstructured":"Daniels AJ, Grizzle MK, Wiard RP, Matthews JE, and Heyer D (2002) Food intake inhibition and reduction in body weight gain in lean and obese rodents treated with GW438014A, a potent and selective NPY-Y5 receptor antagonist. Regul Pept 106: 47\u201354.","DOI":"10.1016\/S0167-0115(02)00034-4"},{"key":"10.1124\/jpet.105.099705_bib12","doi-asserted-by":"crossref","unstructured":"Della-Zuana O, Revereault L, Beck-Sickinger A, Monge A, Caignard DH, Fauchere JL, Henlin JM, Audinot V, Boutin JA, Chamorro S, et al. (2004) A potent and selective NPY Y5 antagonist reduces food intake but not through blockade of the NPY Y5 receptor. Int J Obes Relat Metab Disord 28: 628\u2013639.","DOI":"10.1038\/sj.ijo.0802435"},{"key":"10.1124\/jpet.105.099705_bib13","doi-asserted-by":"crossref","unstructured":"Dube MG, Xu B, Crowley WR, Kalra PS, and Kalra SP (1994) Evidence that neuropeptide Y is a physiological signal for normal food intake. Brain Res 646: 341\u2013344.","DOI":"10.1016\/0006-8993(94)90103-1"},{"key":"10.1124\/jpet.105.099705_bib14","doi-asserted-by":"crossref","unstructured":"Everitt BJ, Hokfelt T, Terenius L, Tatemoto K, Mutt V, and Goldstein M (1984) Differential co-existence of neuropeptide Y (NPY)-like immunoreactivity with catecholamines in the central nervous system of the rat. Neuroscience 11: 443\u2013462.","DOI":"10.1016\/0306-4522(84)90036-8"},{"key":"10.1124\/jpet.105.099705_bib15","doi-asserted-by":"crossref","unstructured":"Gerald C, Walker MW, Criscione L, Gustafson EL, Batzl-Hartmann C, Smith KE, Vaysse P, Durkin MM, Laz TM, Linemeyer DL, et al. (1996) A receptor subtype involved in neuropeptide-Y-induced food intake. Nature (Lond) 382: 168\u2013171.","DOI":"10.1038\/382168a0"},{"key":"10.1124\/jpet.105.099705_bib16","doi-asserted-by":"crossref","unstructured":"Henry M, Ghibaudi L, Gao J, and Hwa JJ (2005) Energy metabolic profile of mice after chronic activation of central NPY Y1, Y2, or Y5 receptors. Obes Res 13: 36\u201347.","DOI":"10.1038\/oby.2005.6"},{"key":"10.1124\/jpet.105.099705_bib17","doi-asserted-by":"crossref","unstructured":"Horvath TL, Naftolin F, Leranth C, Sahu A, and Kalra SP (1996) Morphological and pharmacological evidence for neuropeptide Y-galanin interaction in the rat hypothalamus. Endocrinology 137: 3069\u20133078.","DOI":"10.1210\/endo.137.7.8770933"},{"key":"10.1124\/jpet.105.099705_bib18","doi-asserted-by":"crossref","unstructured":"Hwa JJ, Witten MB, Williams P, Ghibaudi L, Gao J, Salisbury BG, Mullins D, Hamud F, Strader CD, and Parker EM (1999) Activation of the NPY Y5 receptor regulates both feeding and energy expenditure. Am J Physiol 277: R1428\u2013R1434.","DOI":"10.1152\/ajpregu.1999.277.5.R1428"},{"key":"10.1124\/jpet.105.099705_bib19","doi-asserted-by":"crossref","unstructured":"Inui A (1999) Neuropeptide Y feeding receptors: are multiple subtypes involved? Trends Pharmacol Sci 20: 43\u201346.","DOI":"10.1016\/S0165-6147(99)01303-6"},{"key":"10.1124\/jpet.105.099705_bib20","doi-asserted-by":"crossref","unstructured":"Kalra SP, Dube MG, Pu S, Xu B, Horvath TL, and Kalra PS (1999) Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr Rev 20: 68\u2013100.","DOI":"10.1210\/edrv.20.1.0357"},{"key":"10.1124\/jpet.105.099705_bib21","doi-asserted-by":"crossref","unstructured":"Kanatani A, Ishihara A, Iwaasa H, Nakamura K, Okamoto O, Hidaka M, Ito J, Fukuroda T, MacNeil DJ, Van der Ploeg LH, et al. (2000) L-152,804: orally active and selective neuropeptide Y Y5 receptor antagonist. Biochem Biophys Res Commun 272: 169\u2013173.","DOI":"10.1006\/bbrc.2000.2696"},{"key":"10.1124\/jpet.105.099705_bib22","doi-asserted-by":"crossref","unstructured":"Kyrkouli SE, Stanley BG, Hutchinson R, Seirafi RD, and Leibowitz SF (1990) Peptide-amine interactions in the hypothalamic paraventricular nucleus: analysis of galanin and neuropeptide Y in relation to feeding. Brain Res 521: 185\u2013191.","DOI":"10.1016\/0006-8993(90)91541-N"},{"key":"10.1124\/jpet.105.099705_bib23","doi-asserted-by":"crossref","unstructured":"LaVoie EJ, Govil A, Briggs G, and Hoffmann D (1981) Mutagenicity of aminocarbazoles and nitrocarbazoles. Mutat Res 90: 337\u2013344.","DOI":"10.1016\/0165-1218(81)90056-2"},{"key":"10.1124\/jpet.105.099705_bib24","doi-asserted-by":"crossref","unstructured":"Levine AS and Morley JE (1984) Neuropeptide Y: a potent inducer of consummatory behavior in rats. Peptides 5: 1025\u20131029.","DOI":"10.1016\/0196-9781(84)90165-7"},{"key":"10.1124\/jpet.105.099705_bib25","doi-asserted-by":"crossref","unstructured":"Lundberg JM, Terenius L, Hokfelt T, Martling CR, Tatemoto K, Mutt V, Polak J, Bloom S, and Goldstein M (1982) Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. Acta Physiol Scand 116: 477\u2013480.","DOI":"10.1111\/j.1748-1716.1982.tb07171.x"},{"key":"10.1124\/jpet.105.099705_bib26","doi-asserted-by":"crossref","unstructured":"Marsh DJ, Baraban SC, Hollopeter G, and Palmiter RD (1999) Role of the Y5 neuropeptide Y receptor in limbic seizures. Proc Natl Acad Sci USA 96: 13518\u201313523.","DOI":"10.1073\/pnas.96.23.13518"},{"key":"10.1124\/jpet.105.099705_bib27","doi-asserted-by":"crossref","unstructured":"Marsh DJ, Hollopeter G, Kafer KE, and Palmiter RD (1998) Role of the Y5 neuropeptide Y receptor in feeding and obesity. Nat Med 4: 718\u2013721.","DOI":"10.1038\/nm0698-718"},{"key":"10.1124\/jpet.105.099705_bib28","unstructured":"Paxinos G and Watson C (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, San Diego, CA."},{"key":"10.1124\/jpet.105.099705_bib29","doi-asserted-by":"crossref","unstructured":"Pu S, Jain MR, Horvath TL, Diano S, Kalra PS, and Kalra SP (1999) Interactions between neuropeptide Y and gamma-aminobutyric acid in stimulation of feeding: a morphological and pharmacological analysis. Endocrinology 140: 933\u2013940.","DOI":"10.1210\/endo.140.2.6495"},{"key":"10.1124\/jpet.105.099705_bib30","doi-asserted-by":"crossref","unstructured":"Raposinho PD, Broqua P, Pierroz DD, Hayward A, Dumont Y, Quirion R, Junien JL, and Aubert ML (1999) Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype. Endocrinology 140: 4046\u20134055.","DOI":"10.1210\/en.140.9.4046"},{"key":"10.1124\/jpet.105.099705_bib31","doi-asserted-by":"crossref","unstructured":"Raposinho PD, Pedrazzini T, White RB, Palmiter RD, and Aubert ML (2004) Chronic neuropeptide Y infusion into the lateral ventricle induces sustained feeding and obesity in mice lacking either Npy1r or Npy5r expression. Endocrinology 145: 304\u2013310.","DOI":"10.1210\/en.2003-0914"},{"key":"10.1124\/jpet.105.099705_bib32","doi-asserted-by":"crossref","unstructured":"Sawchenko PE, Swanson LW, Grzanna R, Howe PR, Bloom SR, and Polak JM (1985) Colocalization of neuropeptide Y immunoreactivity in brainstem catecholaminergic neurons that project to the paraventricular nucleus of the hypothalamus. J Comp Neurol 241: 138\u2013153.","DOI":"10.1002\/cne.902410203"},{"key":"10.1124\/jpet.105.099705_bib33","doi-asserted-by":"crossref","unstructured":"Stanley BG and Leibowitz SF (1984) Neuropeptide Y: stimulation of feeding and drinking by injection into the paraventricular nucleus. Life Sci 35: 2635\u20132642.","DOI":"10.1016\/0024-3205(84)90032-8"},{"key":"10.1124\/jpet.105.099705_bib34","doi-asserted-by":"crossref","unstructured":"Tatemoto K, Carlquist M, and Mutt V (1982) Neuropeptide Y\u2013a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature (Lond) 296: 659\u2013660.","DOI":"10.1038\/296659a0"},{"key":"10.1124\/jpet.105.099705_bib35","doi-asserted-by":"crossref","unstructured":"Tomaszuk A, Simpson C, and Williams G (1996) Neuropeptide Y, the hypothalamus and the regulation of energy homeostasis. Horm Res 46: 53\u201358.","DOI":"10.1159\/000184996"},{"key":"10.1124\/jpet.105.099705_bib36","doi-asserted-by":"crossref","unstructured":"Turnbull AV, Ellershaw L, Masters DJ, Birtles S, Boyer S, Carroll D, Clarkson P, Loxham SJ, McAulay P, Teague JL, et al. (2002) Selective antagonism of the NPY Y5 receptor does not have a major effect on feeding in rats. Diabetes 51: 2441\u20132449.","DOI":"10.2337\/diabetes.51.8.2441"},{"key":"10.1124\/jpet.105.099705_bib37","doi-asserted-by":"crossref","unstructured":"Wyss P, Stricker-Krongrad A, Brunner L, Miller J, Crossthwaite A, Whitebread S, and Criscione L (1998) The pharmacology of neuropeptide Y (NPY) receptor-mediated feeding in rats characterizes better Y5 than Y1, but not Y2 or Y4 subtypes. Regul Pept 75\u201376: 363\u2013371.","DOI":"10.1016\/S0167-0115(98)00089-5"},{"key":"10.1124\/jpet.105.099705_bib38","doi-asserted-by":"crossref","unstructured":"Zarjevski N, Cusin I, Vettor R, Rohner-Jeanrenaud F, and Jeanrenaud B (1993) Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology 133: 1753\u20131758.","DOI":"10.1210\/endo.133.4.8404618"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524326448?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524326448?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.105.099705","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T21:50:45Z","timestamp":1740001845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524326448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S0022356524326448"],"URL":"https:\/\/doi.org\/10.1124\/jpet.105.099705","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological Characterization and Feeding-Suppressive Property of FMS586 [3-(5,6,7,8-Tetrahydro-9-isopropyl-carbazol-3-yl)-1-methyl-1-(2-pyridin-4-yl-ethyl)-urea Hydrochloride], a Novel, Selective, and Orally Active Antagonist for Neuropeptide Y Y5 Receptor","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.105.099705","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2006 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}